Progenitors in motion: Mechanisms of mobilization of endothelial progenitor cells

British Journal of Clinical Pharmacology

Volumn 68, Issue 4, 2009, Pages 484-492

  Tilling, Lindsey ^a   Chowienczyk, Philip ^a   Clapp, Brian ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelial progenitor cell; Endothelium; Mobilization; Vascular repair

Indexed keywords

CXCL2 CHEMOKINE; ERYTHROPOIETIN; INTERLEUKIN 8; NITRIC OXIDE; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

BONE MARROW CELL; CELL MIGRATION; CELL MOBILIZATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

BONE MARROW CELLS; CARDIOVASCULAR DISEASES; CELL MOVEMENT; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; NITRIC OXIDE; STEM CELLS;

EID: 70449094786     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03486.x     Document Type: Review

References (79)

1. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 : 964 967.
2. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004 109 : 656 663.
3. Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004 14 : 318 322.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999 85 : 221 228.
5. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. Endothelial cells of haemopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000 87 : 728 730.
6. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulation endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003 348 : 581 582.
7. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - results from a large population-based study. PLoS ONE 2007 2 : e975.
8. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 353 : 999 1007. (Pubitemid 41262334)
9. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005 36 : 151 153.
10. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004 24 : 1246 1252.
11. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Haematol 2002 30 : 973 981.
12. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005 106 : 1901 1910.
13. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, Arenzana-Seisdedos F, Magerus A, Caruz A, Fujii N, Nagler A, Lahav M, Szyper-Kravitz M, Zipori D, Lapidot T. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000 106 : 1331 1339.
14. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006 34 : 967 975.
15. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001 97 : 3354 3360.
16. Petit I, Jin D, Rafii S. The SDF1-CXCR4 signalling pathway; a molecular hub modulating neo-angiogenesis. Trends Immunol 2007 28 : 299 307.
17. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schonberger T, Pfisterer I, Hatzopoulos AK, Gawaz M. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006 98 : e2 10.
18. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005 39 : 733 742.
19. Wright DE, Bowman EP, Wagers AJ, Johnson FL, Weissman IL. Haematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002 195 : 1145 1154.
20. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004 10 : 858 864.
21. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004 104 : 3472 3482.
22. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995 92 : 5510 5514.
23. Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krotz F, Sohn H, Klauss V, Weber C, Schober A. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007 27 : 2540 2547.
24. Kollett O, Shivtiel S, Chen YQ. HGF, SDF1 and MMP are involved in stress induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003 112 : 160 169.
25. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N, Margalit R, Zsak M, Nagler A, Hardan I, Resnick I, Rot A, Lapidot T, Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N, Margalit R, Zsak M, Nagler A, Hardan I, Resnick I, Rot A, Lapidot T. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005 6 : 1038 1046.
26. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002 109 : 625 637.
27. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher A, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003 9 : 1370 1376.
28. Fazel SS, Chen L, Angoulvant D, Li S, Weisel RD, Keating A, Li R. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J 2008 22 : 930 940.
29. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003 111 : 187 196.
30. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 2006 108 : 2438 2445.
31. Uy GL, Rettig MP, Cashen AF. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther 2008 8 : 1797 1804.
32. Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, Izawa A, Ise H, Hatake K, Motoyoshi K, Ikeda U. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol 2007 27 : 283 289.
33. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999 18 : 3964 3972. (Pubitemid 29335849)
34. 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000 86 : 1198 1202.
35. Morales-Ruiz M. Vascular endothelial growth factor stimulated actin reorganization and migration of endothelial cells is regulated via serine/threonine kinase Akt. Circ Res 2000 86 : 892 896.
36. + endothelial precursor cells. Circ Res 2001 88 : 167 174.
37. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 2005 65 : 465 472.
38. Bautz F, Rafii S, Kanz L, Mohle R. Expression and secretion of vascular endothelial growth factor-A by cytokine stimulated hematopoietic progenitor cells: possible role in the hematopoietic microenvironment. Exp Haematol 2000 28 : 700 706.
39. Laterveer L, Lindley IJD, Hamilton MS, Willemze R, Fibbe WE. Interleukin A induces rapid mobilization of haematopoietic stem cells with radioprotective capacity and long term myelolymphoid repopulating ability. Blood 1995 85 : 2269 2275.
40. Laterveer L, Zijlemans JMJM, Lindley IJD, Hamilton MS, Willemze R, Fibbe WE. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL8 after pretreatment with stem cell factor. Exp Haematol 1996 24 : 1387 1393.
41. Van Pel M, Van Os R, Velders GA, Hagoort H, Heegaard PMH, Lindley IJD, Willemze R, Fibbe WE. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci USA 2006 103 : 1469 1474.
42. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999 5 : 434 438. (Pubitemid 29180584)
43. Jilma B, Hergovich N, Homoncik M, Jilma-Stohlawetz P, Kreuzer C, Eichler HG, Zellner M, Pugin J. Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans. Br J Haematol 2000 111 : 314 320.
44. Levesque JP, Liu F, Simmons PJ, Betsuyaku T, Senior RM, Pham C, Link DC. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 2004 104 : 65 72. (Pubitemid 38879839)
45. King AG, Horowitz D, Levin R, Farese A, MacVittie T, Pelus LM. Rapid mobilization of murine haematopoietic stem cells with enhanced engraftment properties and evaluation of haematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROβ. Blood 2000 97 : 1534 1542.
46. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood 2004 103 : 110 119.
47. Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, Ratajczak J, Rezzoug F, Ildstad ST, Bolli R, Ratajczak MZ. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004 95 : 1191 1199.
48. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 108 : 391 397.
49. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999 340 : 1801 1811.
50. Yao EH, Yu Y, Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol 2006 7 : 101 108.
51. Tousoulis D, Andreou I, Antoniades C, Tentolouris C, Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008 201 : 236 247.
52. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 : 2781 2786.
53. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 : 666 674.
54. Krantz SB. Erythropoietin. Blood 1991 77 : 419 434.
55. Bahlmann FH, DeGroot K, Duckert T, Niemczyk E, Bahlmann E, Boehm SM, Haller H, Fliser D. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 2003 64 : 1648 1652.
56. Depping R, Kawakami K, Ocker H, Wagner JM, Heringlake M, Noetzold A, Sievers HH, Wagner KF. Expression of the erythropoietin receptor in human heart. J Thorac Cardiovasc Surg 2005 130 : 877 878.
57. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990 87 : 5978 5982.
58. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003 108 : 79 85.
59. Ferrario M, Massa M, Rosti V, Campanelli R, Ferlini M, Marinoni B, De Ferrari GM, Meli V, De Amici M, Repetto A, Verri A, Bramucci E, Tavazzi L. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J 2007 28 : 1805 1813.
60. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DAG, Weisel RD, Fedak PWM, Stewart DJ, Kutryk MJB. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between c-reactive protein and cardiovascular disease. Circulation 2004 109 : 2058 2067.
61. Michalik L, Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 2006 116 : 598 606.
62. Seeger FH, Haendler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rossig L, Corbaz A, Chvatchko Y, Zeiher A, Dimmeler S. p38 Mitogen activated protein kinase downregulates endothelial progenitor cells. Circulation 2005 111 : 1184 1191.
63. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL. Results of targeted anti-tumour necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001 103 : 1044 1047.
64. Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006 65 : 157 163.
65. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Saemann M, Schwarzinger I, Buranyi B, Steiner G, Smolen JS. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis 2007 66 : 1284 1288.
66. Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Bechir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Luscher TF, Gay S, Ruschitzka F. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002 106 : 2184 2187.
67. Wang CH, Verma S, Hsieh IC, Chen YJ, Kuo LT, Yang NI, Wang SY, Wu MY, Hsu CM, Cheng CW, Cherng WJ. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol 2006 41 : 34 43.
68. Bahlmann FH, De Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005 45 : 526 529.
69. Brasier AR, Recinos A III., Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002 22 : 1257 1266.
70. Marumo T, Uchimura H, Hayashi M, Hishikawa K, Fujita T. Aldosterone impairs bone marrow-derived progenitor cell formation. Hypertension 2006 48 : 490 496.
71. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005 23 : 97 104.
72. Ma FX, Ren Q, Han ZC. oxLDL reduced endothelial progenitor cells survival and function via regulating Akt/eNOS signal pathway Zhonghua Xin Xue Guan Bing Za Zhi 2007 35 : 173 177.
73. Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 2006 26 : 1144 1149.
74. Dimmeler S, Assmus B, Hermann C, Haendler J, Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 1998 83 : 334 342.
75. Fulton D. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999 399 : 597 601.
76. Barbero S, Bonavia R, Bajetto A. Stromal cell derived factor 1a stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003 63 : 1969 1974.
77. Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor 1alpha/CXCR4 via PI3L/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007 50 : 274 280.
78. Chong ZZ, Kang JQ, Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 2002 22 : 503 514.
79. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med 2003 228 : 1 14.